Gerd & Nerd Treatment Market Information, By Drug Class, Dosage Form, End User - Americas Forecast Till 2023

Published - May 2019 | Category - Healthcare | No. of Pages - 90 | Published By - Market Research Future

Americas GERD & NERD treatment market is anticipated to grow at the CAGR of 4.02% during the forecast period 2017-2023.

Gerd & Nerd Treatment Market Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid and Liquid), End User (Hospitals & Clinics, Research Centers, And Others) - Americas Forecast Till 2023

In the course of the last two hundred years, indigestion has been one of the common health issues in the U.S. However, a definitive objective of the gastroesophageal reflux treatment has dependably continued as before, which is to stifle the side effects of the GERD patient. GERD influences up to 40% of the U.S. populace in their lifetime and currently, most of the people are facing this health condition. If the GERD isn't appropriately overseen, it can prompt Barrett's esophagus. Early treatment of Barrett's esophagus is significant in light of the fact that it is the essential risk factor for esophageal cancer. The frequency of indigestion issue, otherwise called acid reflux, is quickly expanding around the world. According to various studies almost each individual experiences acid reflux at least once in their lifetime. GERD is one of the regularly watched intermittent gastrointestinal disorders around the world.

Americas GERD & NERD Treatment Market Major Key Players 

AstraZeneca Plc (U.K)
Cempra Inc. (U.S.)
Boston Scientific Corporation (U.S.)
Eisai Co., Ltd. (Japan)
EndoStim Inc. (U.S.)
EndoGastric Solutions Inc. (U.S.)
GlaxoSmithKline Plc (U.K)
Jeil Pharmaceutical Co. Ltd. (South Korea)
Ironwood Pharmaceuticals, Inc. (U.S.)
Johnson & Johnson (U.S.)
Medigus Ltd. (Israel)
Mederi Therapeutics Inc. (U.S.)
Medtronic Inc. (U.S.)
Valeant Pharmaceuticals International, Inc. (Canada)
Allegiant health (U.S.)
Tya pharmaceuticals (U.S.)


Quick Buy

Latest Publications